相关实验视频

Updated: Jun 5, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

循环自然杀手细胞数量与肌痛性骨髓灰质炎1年复发率之间的非线性关系:一项回顾性队列研究

Yifan Zhang¹, Zhiguo Wen¹, Meiqiu Chen¹

¹Department of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.

|December 10, 2024

概括

较高的自然杀手 (NK) 细胞数量可能会防止肌痛性硬化症 (MG) 复发. 这表明NK细胞可能是预测MG复发风险的生物标志物.

科学领域:

免疫学免疫学免疫学
神经学神经学
流行病学流行病学

背景情况:

骨髓灰质炎 (MG) 的复发率很高,这给临床带来了挑战.
识别MG复发的预测因素对于有效的管理至关重要.
循环自然杀手 (NK) 细胞水平被探索为潜在的预测因素.

研究的目的:

调查循环NK细胞数量与MG复发风险之间的关联.
为了确定NK细胞水平是否可以作为MG复发的生物标志物.
探索NK细胞在MG中的潜在免疫调节作用.

主要方法:

对265名MG患者进行了回顾性队列研究.
从电子医疗记录收集的数据 (2015年3月至2022年3月).
分析循环NK细胞数量作为暴露变量和1年MG复发率作为主要结果.

主要成果:

在NK细胞数量和MG复发之间发现了非线性关系.
在NK细胞数量超过5.38的拐点 (RR:0.23) 时,观察到更低的复发风险.
对于NK细胞比例没有发现显著的关联 (RR:0.84).

结论:

周围NK细胞计数可能与MG复发风险有关.
特定的NK细胞计数范围可能表明免疫调节性保护作用.
这些发现表明,个性化的MG治疗策略有潜力.

关键词:

骨髓灰质炎 (Myasthenia gravis) 是一个严重的疾病.自然杀手细胞是自然杀手细胞.非线性非线性复发情况复发情况

更多相关视频

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity

A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity

Published on: August 9, 2017

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...